PV

Praveen Verma

Director Director DIN 03064830
DIN 03064830 First appointment Jul 2010 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Praveen Verma

Data last updated:

Praveen Verma was a Director at Matrix Lifesciences Private Limited (2010–2018) and Director at Cellmob Private Limited (from 2010). The companies operate in Healthcare.

DIN 03064830
Primary Designation Director
Industry Healthcare
First Appointment 08 Jul 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Matrix Lifesciences Private Limited U24230CT2010PTC021937
Director08 Jul 20102010₹62.71 Cr (FY 2025)Active
Cellmob Private Limited U64202CT2010PTC021938
Director08 Jul 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cellmob Private Limited
Matrix Lifesciences Private Limited
Premium access

Shareholding and investment profile for Praveen Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Praveen Verma

Praveen Verma was first appointed on 08 Jul 2010 as Director at Matrix Lifesciences Private Limited.

Praveen Verma held 2 earlier board appointments: Matrix Lifesciences Private Limited (Director, 08 Jul 2010 to 01 Sep 2018); Cellmob Private Limited (Director, from 08 Jul 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available